Atavistik Bio logo

Atavistik Bio

Healthcare
atavistikbio.com
11-50 employees

Atavistik Bio is a biotechnology company focused on developing precision allosteric therapeutics for serious unmet patient needs, particularly in oncology. The company leverages allostery to create superior efficacy and tolerability profiles, with ATV-1601, an allosteric inhibitor for solid tumors, expected to enter clinical trials in early 2025. Led by experienced drug hunters and backed by top-tier investors like The Column Group, Nextech Invest, and Lux Capital, Atavistik Bio aims to accelerate the discovery of innovative treatments.

Open Positions

Executive Assistant

Cambridge, Massachusetts, United States
Posted Feb 6
Full Time

5+ years of professional administrative support experience, 2+ years supporting executive/C-level leaders

Administration JobsBusiness Operations & Strategy Jobs

Senior Scientist, DMPK

Cambridge, Massachusetts, United States
Posted 3 weeks ago
Full Time

PhD, 5+ years of experience in bio/pharmaceutical industry, excellent communication and collaborative skills

Other